Hepatreat Sachet Orange contains L-Ornithine L-Aspartate 3gm, a hepatoprotective agent primarily used to support liver function in patients with hepatic insufficiency and related metabolic disturbances. L-Ornithine L-Aspartate facilitates the detoxification of ammonia by enhancing the urea cycle, thereby reducing hyperammonemia commonly observed in liver diseases such as cirrhosis and hepatic encephalopathy. This compound promotes the synthesis of glutamine in the liver and muscles, aiding in the removal of excess nitrogen and improving overall nitrogen metabolism. Hepatreat Sachet Orange is indicated for the management of chronic liver conditions, including hepatic encephalopathy, where it helps to alleviate symptoms such as confusion, lethargy, and cognitive impairment associated with elevated blood ammonia levels. The sachet formulation allows for convenient oral administration and rapid absorption. It is generally well-tolerated, with minimal adverse effects reported. Hepatreat should be used under medical supervision, particularly in patients with severe hepatic dysfunction or concomitant medical conditions. Dosage and duration of therapy should be individualized based on clinical response and severity of hepatic impairment. This medication serves as an adjunct to dietary and supportive measures aimed at optimizing liver health and patient quality of life.